These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 22536923)
21. Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges. Khan MI; Rath S; Adhami VM; Mukhtar H Pharmacol Res; 2018 Mar; 129():375-387. PubMed ID: 29233676 [TBL] [Abstract][Full Text] [Related]
22. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer. Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383 [TBL] [Abstract][Full Text] [Related]
23. Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome. Mahmoud AM; Ali MM Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871166 [TBL] [Abstract][Full Text] [Related]
25. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Gerhauser C Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508 [TBL] [Abstract][Full Text] [Related]
26. Role of epigenome in tumorigenesis and drug resistance. Hu Q; Baeg GH Food Chem Toxicol; 2017 Nov; 109(Pt 1):663-668. PubMed ID: 28709969 [TBL] [Abstract][Full Text] [Related]
28. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation. Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908 [TBL] [Abstract][Full Text] [Related]
29. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells. Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878 [TBL] [Abstract][Full Text] [Related]
30. Alterations in histone H4 lysine 20 methylation: implications for cancer detection and prevention. Koturbash I; Simpson NE; Beland FA; Pogribny IP Antioxid Redox Signal; 2012 Jul; 17(2):365-74. PubMed ID: 22035019 [TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Santini V; Gozzini A; Ferrari G Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226 [TBL] [Abstract][Full Text] [Related]
33. The Impact of Natural Dietary Compounds and Food-Borne Mycotoxins on DNA Methylation and Cancer. Ghazi T; Arumugam T; Foolchand A; Chuturgoon AA Cells; 2020 Aug; 9(9):. PubMed ID: 32878338 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic Modification in Macrophages: A Promising Target for Tumor and Inflammation-associated Disease Therapy. Sun P; Zhang SJ; Maksim S; Yao YF; Liu HM; Du J Curr Top Med Chem; 2019; 19(15):1350-1362. PubMed ID: 31215380 [TBL] [Abstract][Full Text] [Related]
35. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Link A; Balaguer F; Goel A Biochem Pharmacol; 2010 Dec; 80(12):1771-92. PubMed ID: 20599773 [TBL] [Abstract][Full Text] [Related]
36. Health-promoting role of dietary bioactive compounds through epigenetic modulations: a novel prophylactic and therapeutic approach. Kumari A; Bhawal S; Kapila S; Yadav H; Kapila R Crit Rev Food Sci Nutr; 2022; 62(3):619-639. PubMed ID: 33081489 [TBL] [Abstract][Full Text] [Related]
37. Epigenetic opportunities and challenges in cancer. Best JD; Carey N Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050 [TBL] [Abstract][Full Text] [Related]
38. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance. Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832 [TBL] [Abstract][Full Text] [Related]
39. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602 [TBL] [Abstract][Full Text] [Related]